000 | 01576 a2200481 4500 | ||
---|---|---|---|
005 | 20250514032135.0 | ||
264 | 0 | _c20020521 | |
008 | 200205s 0 0 eng d | ||
022 | _a0029-5566 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBrink, I | |
245 | 0 | 0 |
_aLymph node staging in extracranial head and neck cancer with FDG PET--appropriate uptake period and size-dependence of the results. _h[electronic resource] |
260 |
_bNuklearmedizin. Nuclear medicine _cApr 2002 |
||
300 |
_a108-13 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aBiological Transport |
650 | 0 | 4 | _aFalse Negative Reactions |
650 | 0 | 4 | _aFalse Positive Reactions |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluorodeoxyglucose F18 _xadministration & dosage |
650 | 0 | 4 |
_aHead and Neck Neoplasms _xdiagnostic imaging |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInjections, Intravenous |
650 | 0 | 4 |
_aLymph Nodes _xdiagnostic imaging |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasm Metastasis _xdiagnostic imaging |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 | _aObserver Variation |
650 | 0 | 4 |
_aRadiopharmaceuticals _xadministration & dosage |
650 | 0 | 4 | _aReproducibility of Results |
650 | 0 | 4 | _aTomography, Emission-Computed |
650 | 0 | 4 | _aUltrasonography |
700 | 1 | _aKlenzner, Th | |
700 | 1 | _aKrause, Th | |
700 | 1 | _aMix, M | |
700 | 1 | _aRoss, U H | |
700 | 1 | _aMoser, E | |
700 | 1 | _aNitzsche, E U | |
773 | 0 |
_tNuklearmedizin. Nuclear medicine _gvol. 41 _gno. 2 _gp. 108-13 |
|
999 |
_c11888873 _d11888873 |